Andrej Panic

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography–fusion Biopsy

Stephan Tschirdewahn, Manuel Wiesenfarth, David Bonekamp et al. · European Urology Focus · 2020 · 63 citations

Urology, Engineering, Medical Imaging +5

Are there limits of robotic partial nephrectomy? TRIFECTA outcomes of open and robotic partial nephrectomy for completely endophytic renal tumors

Nina N. Harke, Philipp Mandel, Jörn H. Witt et al. · Journal of Surgical Oncology · 2018 · 50 citations

Sexuality after Male-to-Female Gender Affirmation Surgery

Anja Henkel, Julia Bohr, Christian Rehme et al. · BioMed Research International · 2018 · 47 citations · Full text

Erectile Dysfunction, Pelvic Reconstructive Surgery, Mtf Transsexual Patients +24

Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma

Stephan Tschirdewahn, Andrej Panic, Lukas Püllen et al. · International Journal of Cancer · 2019 · 39 citations · Full text

Renal Pathology, Immunology, Tissue Imp3 Levels +19